Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$42.05 - $47.77 $42,050 - $47,770
-1,000 Reduced 2.12%
46,185 $2.01 Million
Q1 2022

May 11, 2022

BUY
$40.23 - $47.74 $237,920 - $282,334
5,914 Added 14.33%
47,185 $2.06 Million
Q4 2021

Feb 09, 2022

SELL
$38.88 - $45.31 $38,685 - $45,083
-995 Reduced 2.35%
41,271 $1.82 Million
Q3 2021

Nov 09, 2021

SELL
$38.79 - $43.16 $53,530 - $59,560
-1,380 Reduced 3.16%
42,266 $1.62 Million
Q2 2021

Aug 09, 2021

SELL
$36.52 - $41.46 $24,030 - $27,280
-658 Reduced 1.49%
43,646 $1.74 Million
Q1 2021

May 12, 2021

BUY
$34.27 - $40.01 $72,892 - $85,101
2,127 Added 5.04%
44,304 $1.58 Million
Q4 2020

Feb 11, 2021

SELL
$34.07 - $39.94 $556,056 - $651,860
-16,321 Reduced 27.9%
42,177 $1.55 Million
Q3 2020

Nov 13, 2020

SELL
$38.11 - $42.99 $128,240 - $144,661
-3,365 Reduced 5.44%
58,498 $2.2 Million
Q2 2020

Aug 04, 2020

SELL
$37.87 - $43.58 $61,728 - $71,035
-1,630 Reduced 2.57%
61,863 $2.52 Million
Q1 2020

May 11, 2020

SELL
$32.47 - $48.83 $112,573 - $169,293
-3,467 Reduced 5.18%
63,493 $2.41 Million
Q4 2019

Feb 11, 2020

BUY
$42.0 - $48.25 $102,312 - $117,537
2,436 Added 3.78%
66,960 $3.15 Million
Q3 2019

Nov 12, 2019

BUY
$40.46 - $43.52 $47,702 - $51,310
1,179 Added 1.86%
64,524 $2.75 Million
Q2 2019

Aug 13, 2019

SELL
$39.4 - $42.7 $101,258 - $109,739
-2,570 Reduced 3.9%
63,345 $2.54 Million
Q1 2019

May 15, 2019

BUY
$38.57 - $42.69 $291,589 - $322,736
7,560 Added 12.96%
65,915 $2.76 Million
Q4 2018

Feb 06, 2019

BUY
$37.8 - $42.69 $1.97 Million - $2.23 Million
52,181 Added 845.17%
58,355 $2.23 Million
Q2 2018

Apr 15, 2019

SELL
$39.61 - $42.76 $897,206 - $968,556
-22,651 Reduced 78.58%
6,174 $248,000
Q2 2018

Aug 15, 2018

BUY
$39.61 - $42.76 $1.14 Million - $1.23 Million
28,825 New
28,825 $1.16 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Argent Trust CO Portfolio

Follow Argent Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.